Navigation Links
Stipulation Of Dismissal Of Claims By Plaintiff Cornerstone Biopharma, Inc.
Date:7/11/2013

ESTERO, Fla., July 11, 2013 /PRNewswire/ -- On May 16, 2013, United States District Court for the Eastern District of North Carolina DISMISSED with prejudice all claims for copyright and patent infringement asserted by plaintiffs Cornerstone BioPharma, Inc. ("Cornerstone") and J-Med Pharmaceuticals, Inc. ("J-Med") against Vision Pharma, LLC ("Vision"), Sander Busman, Thomas DeStefano, and Michael McAloose.  The dismissal followed the decision of the United States Court of Appeals for the Federal Circuit, upholding the USPTO Board of Patent Appeals and Interferences' rejection of U.S. Patent No. 6,270,796, the sole patent asserted in the case. See In re J-Med Pharmaceuticals, Inc., No. 11-1415 (Fed. Cir.).  On January 11, 2013, the USPTO issued an Ex Parte Reexamination Certificate cancelling all claims of the '796 Patent.

"We were very confident from the absolute beginning that Vision, Thomas DeStefano, Michael McAloose and I would receive a most favorable outcome regarding Cornerstone and J-Med's case against us.  Although these results are especially pleasing, this decision should not have taken so long to happen," said Sander S. Busman, Founder, President & CEO, Vision Pharma. Vision Pharma was represented by Ben Pleune and David Alban of Alston & Bird, LLP. 

About Vision Pharma

Vision Pharma specializes in niche, generic pharmaceuticals with various delivery options and dosage forms.  The company provides quality products at competitive prices while improving the lives of those who take their medicines. The organization's customer service acts promptly to requests while continuously improving to fulfill each customer and patient need. Maintaining additional inventory ensures Vision's ability to provide increased service levels. The pipeline of generic pharmaceuticals planned to market continues to be a strong focus internally and with other pharmaceutical organizations, domestically and internationally. Valuable relationships that are built show true dedication to each partnering company. You can count on Vision Pharma to consider the patient's safety as a top priority when developing and manufacturing their items. To learn more, please visit www.visionpharma.com.

Media Relations Contact:
Sander S. Busman
Vision Pharma
Founder, President & CEO
sbusman@visionpharma.com

 

 


'/>"/>
SOURCE Vision Pharma
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macovens Discontinuance of Certain Products
2. Medstrat Posts Documents Confirming Terms Of Dismissal Of Merges Lawsuit
3. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG
4. Specialty pharmacy utilization management programs and 30-day supply claims may improve patient outcomes, reduce waste
5. Bloomberg BNA Publishes Sixth Edition of False Claims Act Treatise
6. FDA Publicly Challenged to Support Unsubstantiated Claims Regarding Electronic Cigarettes
7. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MAP Pharmaceuticals, Inc. - MAPP
8. Argus Announces Next Generation Pharmacy Claims Processing Solution
9. American Association for Homecare Expects Medicare to Move Past its Deny-at-All-Costs Culture that Routinely Denies Claims for Power Wheelchairs
10. Abbott Sued for False Claims Related to its Blockbuster Drug TriCor
11. Star Scientific, Inc. Issues Statement in Response to Two Plaintiffs Purported Class Action Law Suits and Multiple Press Releases Issued by Plaintiffs Law Firms Trolling for New Clients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... , ... June 19, 2019 , ... ... exclusively for the promotion of social welfare and protection of physicians’ rights, asserts ... than the previous revision and still rely on narrow guidelines as a basis ...
(Date:6/19/2019)... ... June 19, 2019 , ... Center for Vein Restoration (CVR) CEO and Founder, ... CEOs in 2019 . Glassdoor , one of the world’s largest job ... leaders that employees love working for throughout North America and parts of Europe. Dr. ...
(Date:6/19/2019)... Pa. (PRWEB) , ... June 19, 2019 , ... ... nuclear receptor and in vitro toxicology testing solutions, announced the addition of the ... kit expands INDIGO’s existing in vitro toxicology offerings and allows researchers to perform ...
Breaking Medicine Technology:
(Date:6/25/2019)... DETROIT (PRWEB) , ... June 25, 2019 , ... Women’s ... and raised in Louisiana and has been a practicing midwife for over 3 years. ... years. April received her Master’s in Nursing from Frontier University and her undergraduate from ...
(Date:6/25/2019)... ... June 25, 2019 , ... Smile Brands Inc., one of ... than 400 affiliated offices across 17 states, is pleased to announce its latest ... will provide full-service administrative support to the practice, which includes purchasing, payroll, accounting, ...
(Date:6/25/2019)... ... June 25, 2019 , ... The Global Smile Foundation will ... July thanks to 15-year-old Kylie Azizzadeh’s efforts fundraising for the mission. She has already ... before the mission takes place on July 15, 2019. , In 2018, Kylie ...
(Date:6/24/2019)... ... 2019 , ... innovaTel Telepsychiatry, a leading provider of psychiatric ... Advisory Board (SAB) to help inform the Company’s efforts to bring telepsychiatry services ... , We are honored to announce that Linda Rosenberg, immediate past President and ...
(Date:6/24/2019)... (PRWEB) , ... June 24, 2019 , ... Exercising on ... cardio, people often try to mitigate this by running on softer surfaces, such as ... made of a rubber composite. Why not be able to have shock-absorption benefits ...
Breaking Medicine News(10 mins):